Proceeds will fund planned further clinical development of its lead asset, OXU-001, for the treatment of diabetic macular edema (DME), as well as accelerating the development of its early-product ...

Ceros Financial Services will apply the raise to complete initial clinical trials for its incisionless Duodenal Ilial Bypass anastomosis for bariatric and metabolic surgery.

Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device ...

A groundbreaking surgical procedure was successfully performed on a small island in the Mediterranean, marking a significant advancement in spinal surgery. At Hospital Son Llàtzer in Mallorca, Spain, ...

The Aster Guardians Global Nursing Award has today announced its Top 10 finalists for 2025, one of whom will go on to win the grand prize of USD 250,000. The finalists for the fourth edition of the ...

"The recognition of Breakthrough Device Designation for the eShunt System in pediatric aged patients demonstrates the profound need for treatment innovation in this patient population and reinforces ...

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications. The enhanced imaging system features ...

The new Quibim Board of Directors is composed of six members. Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the formation of its new Board of ...

Fred Ong brings more than 30 years of experience in building and growing venture capital-backed healthcare technology companies to his role at Jupiter Endovascular, including playing key roles in ...

Under the agreement, NAMSA will acquire WuXi AppTec facilities in Minnesota and Georgia. NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that it has ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the completion of the ...

The MedTech industry continues to thrive and innovate. According to Markets and Market’s “The Global MedTech Industry Outlook 2024” report, the MedTech market is expected to grow 4% in 2024 to $668.2B ...